Browsing Tag
Akero Therapeutics Inc.
3 posts
From GLP-1 to FGF21: How Novo Nordisk’s Akero Therapeutics deal signals a new era in metabolic drug dominance
Novo Nordisk’s $5.2 B Akero deal adds the FGF21 drug efruxifermin to its MASH portfolio. See how it expands the company’s metabolic dominance.
Regencell Bioscience, D-Wave, Akero lead U.S. gainers as market shrugs off rate jitters
U.S. stocks surged May 20 led by Regencell, D-Wave, and Akero as tech and biotech outperformed amid inflation worries. Read the full market breakdown now.
Why New Fortress Energy, Rocket Companies, and Avidity Biosciences are surging despite economic warnings
Find out which US stocks surged on April 2, 2025, and what rising tariffs and policy shifts mean for investors navigating today’s volatile market.